Literature DB >> 20106919

Isolation of an infectious endogenous retrovirus in a proportion of live attenuated vaccines for pets.

Takayuki Miyazawa1, Rokusuke Yoshikawa, Matthew Golder, Masaya Okada, Hazel Stewart, Massimo Palmarini.   

Abstract

The genomes of all animal species are colonized by endogenous retroviruses (ERVs). Although most ERVs have accumulated defects that render them incapable of replication, fully infectious ERVs have been identified in various mammals. In this study, we isolated a feline infectious ERV (RD-114) in a proportion of live attenuated vaccines for pets. Isolation of RD-114 was made in two independent laboratories using different detection strategies and using vaccines for both cats and dogs commercially available in Japan or the United Kingdom. This study shows that the methods currently employed to screen veterinary vaccines for retroviruses should be reevaluated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106919      PMCID: PMC2838105          DOI: 10.1128/JVI.02715-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Yellow fever vaccination, avian leukosis virus, and cancer risk in man.

Authors:  T D Waters; P S Anderson; G W Beebe; R W Miller
Journal:  Science       Date:  1972-07-07       Impact factor: 47.728

2.  Endogenous type C virus from a cat cell clone with properties distinct from previously described feline type C virus.

Authors:  D M Livingston; G J Todaro
Journal:  Virology       Date:  1973-05       Impact factor: 3.616

3.  Isolation of RD-114-like oncornavirus from a cat cell line.

Authors:  P J Fischinger; P T Peebles; S Nomura; D K Haapala
Journal:  J Virol       Date:  1973-06       Impact factor: 5.103

4.  Contaminant viruses in two live virus vaccines produced in chick cells.

Authors:  R J Harris; R M Dougherty; P M Biggs; L N Payne; A P Goffe; A E Churchill; R Mortimer
Journal:  J Hyg (Lond)       Date:  1966-03

5.  Molecular genetic characterization of the RD-114 gene family of endogenous feline retroviral sequences.

Authors:  R H Reeves; S J O'Brien
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

6.  Basolateral maturation of retroviruses in polarized epithelial cells.

Authors:  M G Roth; R V Srinivas; R W Compans
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

Review 7.  RD-114 virus: characterization and identification.

Authors:  R M McAllister; M B Gardner; M O Nicolson; R V Gilden; N Davidson
Journal:  Prog Exp Tumor Res       Date:  1978

Review 8.  Natural expression of feline type-C virus genomes, prevalence of detectable felv and RD-114 GS antigen, type-C particles and infectious virus in postnatal and fetal cats.

Authors:  M B Gardner; S Rasheed; R W Rongey; H P Charman; B Alena; R V Gilden; R J Huebner
Journal:  Int J Cancer       Date:  1974-07-15       Impact factor: 7.396

9.  Adventitious viral genomes in vaccines but not in vaccinees.

Authors:  R A Weiss
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

10.  Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.

Authors:  Vincent C Lombardi; Francis W Ruscetti; Jaydip Das Gupta; Max A Pfost; Kathryn S Hagen; Daniel L Peterson; Sandra K Ruscetti; Rachel K Bagni; Cari Petrow-Sadowski; Bert Gold; Michael Dean; Robert H Silverman; Judy A Mikovits
Journal:  Science       Date:  2009-10-08       Impact factor: 47.728

View more
  14 in total

1.  Sequence comparison of three infectious molecular clones of RD-114 virus.

Authors:  Sayumi Shimode; Rokusuke Yoshikawa; Shigeki Hoshino; Yuki Nakaya; Shoichi Sakaguchi; Takeshi Kobayashi; Takayuki Miyazawa
Journal:  Virus Genes       Date:  2012-05-26       Impact factor: 2.332

2.  Characterization of RD-114 virus isolated from a commercial canine vaccine manufactured using CRFK cells.

Authors:  Rokusuke Yoshikawa; Eiji Sato; Tatsuhiko Igarashi; Takayuki Miyazawa
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

Review 3.  Transmission, Evolution, and Endogenization: Lessons Learned from Recent Retroviral Invasions.

Authors:  Alex D Greenwood; Yasuko Ishida; Sean P O'Brien; Alfred L Roca; Maribeth V Eiden
Journal:  Microbiol Mol Biol Rev       Date:  2017-12-13       Impact factor: 11.056

4.  Experimental infection of dogs with a feline endogenous retrovirus RD-114.

Authors:  Rie Narushima; Noriyuki Horiuchi; Tatsufumi Usui; Takashi Ogawa; Toshio Takahashi; Tomoaki Shimazaki
Journal:  Acta Vet Scand       Date:  2011-01-27       Impact factor: 1.695

5.  Cloning and characterization of the antiviral activity of feline Tetherin/BST-2.

Authors:  Aiko Fukuma; Masumi Abe; Yuko Morikawa; Takayuki Miyazawa; Jiro Yasuda
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

6.  Of Mice and Men: On the Origin of XMRV.

Authors:  Antoinette Cornelia van der Kuyl; Marion Cornelissen; Ben Berkhout
Journal:  Front Microbiol       Date:  2011-01-17       Impact factor: 5.640

7.  Viral and cellular requirements for the budding of feline endogenous retrovirus RD-114.

Authors:  Aiko Fukuma; Masumi Abe; Shuzo Urata; Rokusuke Yoshikawa; Yuko Morikawa; Takayuki Miyazawa; Jiro Yasuda
Journal:  Virol J       Date:  2011-12-14       Impact factor: 4.099

8.  Phylogeny-directed search for murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome and prostate cancer.

Authors:  Jonas Blomberg; Ali Sheikholvaezin; Amal Elfaitouri; Fredrik Blomberg; Anna Sjösten; Johan Mattson Ulfstedt; Rüdiger Pipkorn; Clas Källander; Christina Ohrmalm; Göran Sperber
Journal:  Adv Virol       Date:  2011-09-04

9.  Complete genome sequences of two feline leukemia virus subgroup B isolates with novel recombination sites.

Authors:  H Stewart; O Jarrett; M J Hosie; B J Willett
Journal:  Genome Announc       Date:  2013-01-15

10.  A new approach to establish a cell line with reduced risk of endogenous retroviruses.

Authors:  Aiko Fukuma; Rokusuke Yoshikawa; Takayuki Miyazawa; Jiro Yasuda
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.